OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 153 filers reported holding OCULAR THERAPEUTIX INC in Q1 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,912,452 | -57.4% | 680,588 | -37.1% | 0.12% | -58.5% |
| Q3 2022 | $4,491,000 | +6.9% | 1,082,103 | +3.6% | 0.28% | +16.9% |
| Q2 2022 | $4,200,000 | -22.4% | 1,044,732 | -4.4% | 0.24% | +1.7% |
| Q1 2022 | $5,411,000 | -22.2% | 1,093,148 | +9.6% | 0.24% | -2.4% |
| Q4 2021 | $6,951,000 | +85.0% | 997,226 | +165.4% | 0.24% | +88.5% |
| Q3 2021 | $3,758,000 | -79.9% | 375,806 | -71.5% | 0.13% | -78.8% |
| Q2 2021 | $18,700,000 | -15.8% | 1,318,737 | -2.6% | 0.61% | -17.1% |
| Q1 2021 | $22,217,000 | -4.3% | 1,353,896 | +20.7% | 0.74% | -8.7% |
| Q4 2020 | $23,218,000 | – | 1,121,628 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |